Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial

B Nourbakhsh, N Revirajan, B Morris… - The Lancet …, 2021 - thelancet.com
Background Methylphenidate, modafinil, and amantadine are commonly prescribed
medications for alleviating fatigue in multiple sclerosis; however, the evidence supporting …
被引用次数：141 相关文章

Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial

B Nourbakhsh, N Revirajan, B Morris… - The Lancet …, 2021 - pure.johnshopkins.edu
Background: Methylphenidate, modafinil, and amantadine are commonly prescribed
medications for alleviating fatigue in multiple sclerosis; however, the evidence supporting …

Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.

B Nourbakhsh, N Revirajan, B Morris… - Lancet …, 2021 - escholarship.org
BACKGROUND: Methylphenidate, modafinil, and amantadine are commonly prescribed
medications for alleviating fatigue in multiple sclerosis; however, the evidence supporting …
[HTML] nih.gov

[HTML][HTML] Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomized, crossover, double-blind trial

B Nourbakhsh, N Revirajan, B Morris… - The Lancet …, 2021 - ncbi.nlm.nih.gov
Background Methylphenidate, modafinil, and amantadine are commonly prescribed
medications for alleviating fatigue in multiple sclerosis (MS); however, the evidence …
[PDF] academia.edu

[PDF][PDF] Health Research Alliance

B Nourbakhsh, N Revirajan, B Morris, C Cordano… - Lancet …, 2021 - academia.edu
Background—Methylphenidate, modafinil, and amantadine are commonly prescribed
medications for alleviating fatigue in multiple sclerosis (MS); however, the evidence …

Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.

B Nourbakhsh, N Revirajan, B Morris… - The Lancet …, 2020 - europepmc.org
Background Methylphenidate, modafinil, and amantadine are commonly prescribed
medications for alleviating fatigue in multiple sclerosis; however, the evidence supporting …

Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial

B Nourbakhsh, N Revirajan, B Morris, C Cordano… - The Lancet …, 2021 - Elsevier
Background Methylphenidate, modafinil, and amantadine are commonly prescribed
medications for alleviating fatigue in multiple sclerosis; however, the evidence supporting …

Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial

B Nourbakhsh, N Revirajan, B Morris… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Methylphenidate, modafinil, and amantadine are commonly prescribed
medications for alleviating fatigue in multiple sclerosis; however, the evidence supporting …

Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.

B Nourbakhsh, N Revirajan, B Morris… - The Lancet …, 2020 - europepmc.org
Background Methylphenidate, modafinil, and amantadine are commonly prescribed
medications for alleviating fatigue in multiple sclerosis; however, the evidence supporting …